Literature DB >> 8349861

Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study.

L Weinrauch1, F Cawich, P Craig, J X Sosa, J el-On.   

Abstract

BACKGROUND: Many studies have been performed during the past decade to find an effective topical therapy for cutaneous leishmaniasis (CL).
OBJECTIVE: Our purpose was to evaluate the effect of paromomycin ointment (P-ointment) containing 15% paromomycin sulfate and 12% methylbenzethonium chloride on Belizean patients with New World CL.
METHODS: Fifty-three patients were treated twice daily for 14 to 21 days with P-ointment.
RESULTS: Sixty-eight percent of the patients healed, 6% had a delayed cure, and 26% did not respond. No toxic effects from the ointment were observed.
CONCLUSION: Topical paromomycin is as efficacious in the treatment of New World CL as other currently accepted modalities that are potentially more toxic.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349861     DOI: 10.1016/0190-9622(93)70209-c

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

1.  Polymerase chain reaction detection of Leishmania kDNA from the urine of Peruvian patients with cutaneous and mucocutaneous leishmaniasis.

Authors:  Nicolas Veland; Diego Espinosa; Braulio Mark Valencia; Ana Pilar Ramos; Flor Calderon; Jorge Arevalo; Donald E Low; Alejandro Llanos-Cuentas; Andrea K Boggild
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

2.  Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials.

Authors:  Dae Hyun Kim; Hye Jin Chung; Joachim Bleys; Reza F Ghohestani
Journal:  PLoS Negl Trop Dis       Date:  2009-02-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.